Inferior Survival in Double Refractory Large B-Cell Lymphoma Eligible for Third-Line CD19 Chimeric Antigen T-Cell Therapy
Authors
Chathuri Abeyakoon,
Sita BhellaKatrina Hueniken,
Rachel Aitken,
Carmel Waldron,
Anca Prica,
Vishal Kukreti,
Robert Kridel,
Abi Vijenthira,
Christine Chen,
Chloe Yang,
Richard Tsang,
David Hodgson,
Danielle Rodin,
Nauman Malik,
Woodrow Wells,
Michael Crump +15 authors
,
John Kuruvilla Tip Tip